Rigel Pharmaceuticals reported $28.9M in Trade Debtors for its fiscal quarter ending in June of 2024.





Trade Debtors Change Date
Agenus USD 22.34M 107K Mar/2026
Amgen USD 10.35B 126M Sep/2026
Anika Therapeutics USD 29.33M 661K Dec/2025
Arrowhead Research USD 8.56M 7.13M Jun/2026
AstraZeneca USD 18.87B 11M Sep/2026
BioMarin Pharmaceutical USD 1.08B 15.31M Sep/2026
Bristol-Myers Squibb USD 12.85B 976M Sep/2026
Celldex Therapeutics USD 355K 125K Sep/2026
Daiichi Sankyo JPY 700.97B 24.05B Sep/2026
Eli Lilly USD 23.48B 2.3B Jun/2026
Halozyme Therapeutics USD 518.59M 65.26M Sep/2026
Heron Therapeutics USD 89.59M 8.54M Dec/2025
Intrexon USD 1.02M 559K Jun/2024
Ionis Pharmaceuticals USD 88M 29.15M Sep/2026
Karyopharm Therapeutics USD 23.36M 2.82M Mar/2026
Ligand Pharmaceuticals USD 69.92M 15.12M Jun/2026
MacroGenics USD 144.17M 133.75M Jun/2026
Neurocrine Biosciences USD 957.3M 70.3M Sep/2026
Pfizer USD 17.57B 1.38B Sep/2026
Regeneron Pharmaceuticals USD 6.57B 834.4M Jun/2026
Rigel Pharmaceuticals USD 28.9M 1.39M Jun/2024
Sangamo BioSciences USD 581K 110K Jun/2024
Ultragenyx Pharmaceutical USD 200M 140M Jun/2026
Veracyte USD 56.79M 2.61M Sep/2026